| Date | Name | Title | Type | Shares Traded | Price Range | |||
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2010 | vagelos p roy | Director | Disposition (Non Open Market) | 125,000 | n/a | |||
| Jul 7, 2010 | vagelos p roy | Director | Acquisition (Non Open Market) | 125,000 | n/a | |||
| Jul 2, 2010 | vagelos p roy | Director | Disposition (Non Open Market) | 9,021 | n/a | |||
| Jun 18, 2010 | vagelos p roy | Director | Acquisition (Non Open Market) | 31,761 | n/a | |||
| Jun 18, 2010 | vagelos p roy | Director | Disposition (Non Open Market) | 31,761 | n/a | |||
| Jun 14, 2010 | ryan arthur f | Director | Buy | 10,000 | 26.98 | |||
| Jun 9, 2010 | sing george l | Director | Option Execute | 5,000 | 25.43 | |||
| Jun 4, 2010 | goldberg murray a | Officer | Automatic Sell | 6,100 | 28.56 - 29.37 | |||
| Jun 3, 2010 | goldberg murray a | Officer | Automatic Sell | 13,900 | 30.02 | |||
| Jun 3, 2010 | goldberg murray a | Officer | Option Execute | 20,000 | 13.00 | |||
| Jun 3, 2010 | kolinski stuart | Officer | Automatic Sell | 6,784 | 30.02 | |||
| Jun 3, 2010 | kolinski stuart | Officer | Option Execute | 12,500 | 8.50 | |||
| Jun 2, 2010 | baker charles a | Director | Option Execute | 5,000 | 25.43 | |||
| May 27, 2010 | gilman alfred g | Director | Disposition (Non Open Market) | 4,553 | 27.92 | |||
| May 27, 2010 | gilman alfred g | Director | Option Execute | 5,000 | 25.43 | |||
| May 19, 2010 | brown michael s | Director | Sell | 524 | 27.73 | |||
| May 18, 2010 | brown michael s | Director | Disposition (Non Open Market) | 4,476 | 28.40 | |||
| May 18, 2010 | brown michael s | Director | Option Execute | 5,000 | 25.43 | |||
| May 18, 2010 | sing george l | Director | Buy | 5,000 | 28.44 | |||
| May 18, 2010 | sing george l | Director | Buy | 2,500 | 28.64 | |||
| ||||||||
Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Stock Information
| NASDAQ:REGN
$23.28 + 0.80 |
Sep 2, 2010
11:32 AM ET |
Quotes delay at least 20min., by eSignal.
